Detalhe da pesquisa
1.
Genetic Drivers of Kidney Defects in the DiGeorge Syndrome.
N Engl J Med
; 376(8): 742-754, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28121514
2.
Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
J Immunol
; 188(11): 5365-76, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22529296
3.
The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.
J Vis Exp
; (104)2015 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26484588
4.
Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2.
Cancer Res
; 74(4): 1067-78, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24398473
5.
Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics.
Nat Commun
; 4: 2863, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24287595
6.
Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblasts.
J Cell Sci
; 119(Pt 9): 1896-902, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16636074
7.
Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration.
Proc Natl Acad Sci U S A
; 102(10): 3685-90, 2005 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-15728377